MedTrace Logo

P4 Approach in Diabetes Type 2

NCT02196350 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-10-25

No results posted yet for this study

Summary

The study aims to assess the impact of the P4 approach on established markers of glucose metabolism in type 2 diabetics.

Secondary objectives are examination of the changes in physical characteristics, quality of life and the indices for beta cell function, hepatic insulin resistance and muscle insulin resistance .

Conditions

Interventions

BEHAVIORAL

Intervention A: Diet

subjects visit the dietitian at week 0, 1, 2, 6, 10 and 13 for dietary advice

BEHAVIORAL

Intervention B: Exercise

subjects visit the physiotherapist three times weekly; subjects visit the dietitian at week 0, 1, 2, 6, 10 and 13 for dietary advice.

BEHAVIORAL

Intervention C: Diet and Exercise

subjects visit the physiotherapist three times weekly; subjects visit the dietitian at week 0, 1, 2, 6, 10 and 13 for dietary advice.

Sponsors & Collaborators

  • W.J. Pasman

    lead OTHER

Principal Investigators

  • Wilrike Pasman, PhD · Netherlands Organisation for Applied Scientific Research (TNO)

  • Peter van Dijken, Dr. · Netherlands Organisation for Applied Scientific Research (TNO)

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02196350 on ClinicalTrials.gov